tiprankstipranks
Advertisement
Advertisement

AU:ARX Stock Latest News

Aroa Biosurgery Corrects Typo in FY26 Results Investor Presentation
Company AnnouncementsAroa Biosurgery Corrects Typo in FY26 Results Investor Presentation
8d ago
ARX
Aroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment
PremiumCompany Announcements
Aroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment
8d ago
ARX
Aroa Biosurgery Beats FY26 Guidance on Strong Myriad Sales and Margin Lift
PremiumCompany Announcements
Aroa Biosurgery Beats FY26 Guidance on Strong Myriad Sales and Margin Lift
1M ago
ARX
Aroa Biosurgery Seeks ASX Quotation for New Share Issue
PremiumCompany Announcements
Aroa Biosurgery Seeks ASX Quotation for New Share Issue
2M ago
ARX
Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution
PremiumCompany Announcements
Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution
2M ago
ARX
Aroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers
PremiumCompany AnnouncementsAroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers
2M ago
ARX
Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares
Premium
Company Announcements
Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares
2M ago
ARX
Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial
Premium
Company Announcements
Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial
4M ago
ARX
Aroa Biosurgery Seeks ASX Quotation for New Shares Issued Under Employee Incentive Scheme
PremiumCompany Announcements
Aroa Biosurgery Seeks ASX Quotation for New Shares Issued Under Employee Incentive Scheme
4M ago
ARX
Aroa Biosurgery Issues Investor-Focused February 2026 Business Update
PremiumCompany Announcements
Aroa Biosurgery Issues Investor-Focused February 2026 Business Update
4M ago
ARX
Aroa Biosurgery Poised to Gain From US Reimbursement Shift as New Data Backs Myriad
PremiumCompany Announcements
Aroa Biosurgery Poised to Gain From US Reimbursement Shift as New Data Backs Myriad
4M ago
ARX
Aroa Biosurgery’s Symphony Trial Completion: What Diabetic Ulcer Data Could Mean for AU:ARX
PremiumCompany Announcements
Aroa Biosurgery’s Symphony Trial Completion: What Diabetic Ulcer Data Could Mean for AU:ARX
4M ago
ARX
Aroa Biosurgery Schedules Investor Webinar to Detail Symphony Reimbursement and Clinical Data
PremiumCompany AnnouncementsAroa Biosurgery Schedules Investor Webinar to Detail Symphony Reimbursement and Clinical Data
4M ago
ARX
Aroa Biosurgery Study Backs Efficacy and Cost Edge of Myriad Trauma Scaffold
Premium
Company Announcements
Aroa Biosurgery Study Backs Efficacy and Cost Edge of Myriad Trauma Scaffold
4M ago
ARX
Aroa Biosurgery Options Lapse Following Unmet Vesting Conditions
Premium
Company Announcements
Aroa Biosurgery Options Lapse Following Unmet Vesting Conditions
5M ago
ARX
Aroa’s Symphony Wins Extended US Medicare Access as CMS Tightens Skin Substitute Rules
PremiumCompany Announcements
Aroa’s Symphony Wins Extended US Medicare Access as CMS Tightens Skin Substitute Rules
6M ago
ARX
Aroa Biosurgery Ltd Reports Half-Year 2026 Results
PremiumCompany Announcements
Aroa Biosurgery Ltd Reports Half-Year 2026 Results
6M ago
ARX
Aroa Biosurgery Achieves Strong Revenue Growth and Financial Stability in H1 FY26
PremiumCompany Announcements
Aroa Biosurgery Achieves Strong Revenue Growth and Financial Stability in H1 FY26
6M ago
ARX
Aroa Biosurgery Reports Improved Financial Performance Amid Sales Growth
PremiumCompany Announcements
Aroa Biosurgery Reports Improved Financial Performance Amid Sales Growth
6M ago
ARX
Aroa Biosurgery Issues Unquoted Equity Securities for Employee Incentive
PremiumCompany AnnouncementsAroa Biosurgery Issues Unquoted Equity Securities for Employee Incentive
7M ago
ARX
Aroa Biosurgery to Host Investor Event on H1 FY26 Results and Outlook
Premium
Company Announcements
Aroa Biosurgery to Host Investor Event on H1 FY26 Results and Outlook
7M ago
ARX
Aroa Biosurgery Announces Director Departure and Securities Update
Premium
Company Announcements
Aroa Biosurgery Announces Director Departure and Securities Update
7M ago
ARX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >